3rd Annual Dermatology Drug Development Summit

3rd Annual Dermatology Drug Development Summit is organized by Hanson Wade and will be held from Nov 19 - 21, 2019 at Aloft Boston Seaport District, Boston, Massachusetts, United States of America.

Enhancing the Development and Bringing to Market of New Dermatological Therapeutic Options

Description:

The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need.

The dermatology space continues to undergo huge therapeutic innovation and growing competitive pressure, driven by the evolving understanding of the pathophysiology of skin diseases, as well as in the available treatment options for chronic, moderate to severe dermatological conditions and high unmet need that affects the lives of patients worldwide.

The 3rd Annual Dermatology Drug Development Summit provides leading industry experts with a unique forum to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways, to unveiling critical preclinical insights, discussing formulation strategies, defining the optimal clinical development plans or evaluating commercialization approaches.

Key Benefits of Attending:
• Accelerate the development of innovative dermatological therapies
• Hear from KOLs how to tackle the challenges to bring better dermatology drugs to market
• Be in tune with growing excitement in the dermatology drug development space

Key Highlights You Cannot Miss:
• Incyte Corporation
• LEO Pharma 
• Galderma 
• Sienna Biopharmaceuticals 
• FDA
• Krystal Biotech
• Incyte Corporation
• Dermavant Sciences

Pre-Conference Workshop Day - Tuesday (Nov 19, 2019)

Workshop A- 8:00am – 10:45am

Novel Translational & Clinical Development Approaches For Topicals
In this workshop, real-life data and hypothetical examples will be used to explore alternative strategies for early development of topical products. Cases will be shown illustrating how the measurement of real-time PK/PD, establishing proof-of-pharmacology in challenge models, or assessing safety via dermal PK can be applied to de-risk development and build confidence.

Workshop B- 11:00am – 1:45pm

The Future of Drug Development in Dermatology: Indications & Implications
Key topics to be addressed include:
• Current and future dermatology drug landscape
• Differentiation strategies in the busy development space
• Unmet-need-driven innovation
• Building patients’ perspectives into the foundation of product strategy
• Acceleration of the drug development process

Workshop C- 2:00pm – 5:00pm
A key area of focus for drug developers working in dermatology is to ensure the optimization of drug delivery platforms and formulation approaches. In this workshop, you will have the opportunity to gain in depth insights from leading experts in this space that will help you advance your topical development.

Start-Up Focus Roundtable - 5:15pm – 7:00pm

Backing the Bet: Exploring the Challenges of Funding Development
The session will explore key topics, including:
• Going public vs staying private
• Judging the macro environment
• The stories investors buy

Additional details will be posted as soon as information is available.